Clinical-stage oncology company developing PIKTOR, an oral multi-node PI3K/AKT/mTOR pathway combination; formerly Sensei Biotherapeutics. [BIOTECH-2026-10-04]
Search transcripts, quotes, and verified statements from every Faeth Therapeutics executive via our platform or API.